دورية أكاديمية

Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study.

التفاصيل البيبلوغرافية
العنوان: Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study.
المؤلفون: Furubayashi, Nobuki, Minato, Akinori, Tomoda, Toshihisa, Masaoka, Hiroyuki, Hori, Yoshifumi, Kiyoshima, Keijiro, Negishi, Takahito, Haraguchi, Yusuke, Koga, Toshiki, Song, Yoohyun, Harada, Kenichi, Kuroiwa, Kentaro, Seki, Narihito, Fujimoto, Naohiro, Nakamura, Motonobu
المصدر: Anticancer Res ; ISSN:1791-7530 ; Volume:44 ; Issue:7
بيانات النشر: HighWire
سنة النشر: 2024
المجموعة: PubMed Central (PMC)
مصطلحات موضوعية: Urothelial carcinoma, cutaneous toxicity, enfortumab vedotin, renal function toxicity
الوصف: The clinical outcomes associated with cutaneous toxicity and changes in the renal function of patients receiving enfortumab vedotin (EV) for advanced urothelial carcinoma (UC) is unclear.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: https://doi.org/10.21873/anticanres.17115Test; https://pubmed.ncbi.nlm.nih.gov/38925809Test
DOI: 10.21873/anticanres.17115
الإتاحة: https://doi.org/10.21873/anticanres.17115Test
https://pubmed.ncbi.nlm.nih.gov/38925809Test
حقوق: Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
رقم الانضمام: edsbas.E1AF3F06
قاعدة البيانات: BASE